RWS Acquires Leading Life Sciences Translation Company
Corporate Translations Inc (CTi), the world's leading life sciences translation and linguistic validation provider, has been acquired by RWS, the leading provider of intellectual property support services. The acquisition is in line with the strategy of complementing organic growth with selective acquisition.
CTi is based in Connecticut, USA and founded in 1990 to cater for the growing demand for high quality translation services in the life sciences sector. It is now a recognised leader in successfully managing complex translation projects on behalf of the world's top pharmaceutical and biotech companies and their Clinical Research Organisation partners. As CTi's customers operate in highly regulated and audited industries, they place a premium on high quality translations being delivered to specific deadlines. CTi enjoys a preferred supplier relationship with many of its customers, with extraordinary penetration of the blue chip life science community.
RWS already focuses on the life sciences sector, through its patent translation and filing solutions, and with its separate Medical Translation Division which includes the linguistic validation specialist PharmaQuest.
The scale of CTi, combined with the specialist RWS divisions will immediately transform the Group to a preeminent position in life sciences translations and linguistic validation and further enhance its competitive standing amongst the largest specialist translation companies in the world.
Andrew Brode, Chairman of RWS Holdings, commented:
"We are delighted to have acquired CTi, which greatly expands our exposure to the attractive and growing life sciences sector through a world leading language services provider in this field. With its focus on supporting clients in the delivery of their intellectual property pipelines, CTi is an excellent fit with RWS’ leading position in IP service provision.
“We look forward to building on CTi’s strong reputation and financial track record, particularly as RWS adds its own life science division and client base, and provides a platform from which it can achieve further expansion into the European life science support services sector.
RWS Group is a global leader in language services, employing over 600 staff worldwide. It is a leading provider of intellectual property support services and high level technical translation and localisation services for clients in the engineering, electronics, pharmaceutical and life sciences, chemical, legal and financial industries.
@RWS delighted @CorpTransInc is part of the Group. Their life sciences translation services are an excellent fit with RWS IP services
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
CELLTRION15.12.2017 23:15 | pressemeddelelse
Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar
TAKEDA15.12.2017 13:36 | pressemeddelelse
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
TWISPAY15.12.2017 13:23 | pressemeddelelse
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards
PEACE-FORUM15.12.2017 12:40 | pressemeddelelse
Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum
CA-KENNEDY-WILSON15.12.2017 12:02 | pressemeddelelse
Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million
NV-NAC-FOUNDATION15.12.2017 10:02 | pressemeddelelse
AML BitCoin Enters Phase II of ICO
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum